A Phase I/II Study of Recombinant Desulfato Hirudin, Lepirudin (Refludan) in Small Cell Lung Cancer Patients Previously Treated With Chemotherapy
Phase of Trial: Phase I/II
Latest Information Update: 09 Aug 2016
At a glance
- Drugs Lepirudin (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 27 Jun 2016 Status changed from completed to discontinued.
- 15 Sep 2005 New trial record.